Patently-O

MARCH 27, 2025

by Dennis Crouch In a significant decision, the Federal Circuit has established a more rigorous test for determining when a published patent application claiming priority to a provisional application can be considered prior art as of its provisional filing date. In re Riggs , Case No. 2022-1945 (Fed.

Art 70

Art Confidentiality Publishing Inventor 70

SpicyIP

JANUARY 20, 2025

Deepak Gupta & Ors Do trade secrets/confidential information need to have economic or commercial value? The Court quashed the impugned hearing notice and the opposition Boards recommendations and issued directions for a fresh adjudication of the opposition application, permitting both parties to submit evidence within three weeks.

Registering Trademarks 102

Registering Trademarks Trademark Registration IP 102

SpicyIP

FEBRUARY 23, 2025

A quick glance at last week – Madras HC accepts a US District Court’s Letter Rogatory to furnish confidential information, a look at Functional Fallacies in Thomson Reuters vs Ross Intelligence and many more. on 14 February, 2025, (Delhi HC) Manash Lifestyle Pvt. The deadline to file the comments is February 28.

Confidentiality 59

Confidentiality Trademark Copyright Infringement Music 59

SpicyIP

FEBRUARY 23, 2025

Softgel: The Errors of Comity The Madras High Court accepted a Letter Rogatory from The US District Court in Delaware directing India-based Softgel Healthcare to furnish confidential information to the US Court. on 14 February, 2025, (Delhi HC) Manash Lifestyle Pvt. Praharsh Gour writes on this order, highlighting the above omission.

Confidentiality 52

Confidentiality Trademark Copyright Infringement Music 52

SpicyIP

DECEMBER 2, 2024

Here is our recap of last week’s top IP developments including summaries of the posts on IPO’s patent application rejection of HIV drug Dolutegravir, another judgement in the long-running Section 3(k) saga, this time on the patentability of business methods and the DHC IPD’s Annual Report 2023-24. Read more for the details.

Invention 52

Invention Trademark Reporting Editing 52

The IPKat

NOVEMBER 14, 2022

The latter, contrary to what it might appear from its date of adoption (2014), is a regulation that is certainly topical, having started to take effect as of 31 July 2022, with a transitional period that will last until 31 January 2025, but which will see a first and fundamental provision entering into force on 31 January 2023.

IP 78

IP Marketing Marketing Confidentiality 78

Bio Law Blog

JUNE 21, 2020

On May 28, Alexion and Amgen entered into a confidential settlement agreement to terminate the IPRs. Pursuant to the terms of the settlement agreement, effective March 1, 2025 (or earlier in certain circumstances), Alexion grants to Amgen a nonexclusive, royalty-free license under U.S. an eculizumab product.

Marketing 52

Marketing Marketing Settlement Patent 52